Endpoint Outcomes

Pharmaceuticals

United States, Massachusetts

$10M to $25M

11-50

RxEDO

Pharmaceuticals

United States, Texas

$10M to $25M

11-50

CyDex Pharmaceuticals

Pharmaceuticals

United States, Kansas

$10M to $25M

11-50

Johnson's Pharmacy Services

Pharmaceuticals

United States, Pennsylvania

$10M to $25M

11-50

Parkside Pharmacy

Pharmaceuticals

United States, Indiana

$10M to $25M

11-50

BioMonde UK

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Keystone State Testing

Pharmaceuticals

United States, Pennsylvania

$10M to $25M

11-50

Jupiter Life Science Consulting

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Lincourt Pharmacy

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

Long Term Care Rx

Pharmaceuticals

United States, Missouri

$10M to $25M

11-50

Lindburg Pharmacy

Pharmaceuticals

United States, Kansas

$10M to $25M

11-50

Dg Enterprise

Pharmaceuticals

United States, Texas

$10M to $25M

11-50

SFJ Pharmaceuticals

Pharmaceuticals

United States, California

$10M to $25M

11-50

Cochran Wholesale Pharmaceutical

Pharmaceuticals

United States, Georgia

$10M to $25M

11-50

Suncoast Clinical Research

Pharmaceuticals

United States, Florida

$10M to $25M

11-50

HEMA Biologics

Pharmaceuticals

United States, Kentucky

$10M to $25M

11-50

InClinica

Pharmaceuticals

United States, Pennsylvania

$10M to $25M

11-50

Centrexion Therapeutics

Pharmaceuticals

United States, Massachusetts

$10M to $25M

11-50

Schraft's 2.0

Pharmaceuticals

United States, New Jersey

$10M to $25M

11-50

V-Care Specialty Pharmacy

Pharmaceuticals

United States, Massachusetts

$10M to $25M

11-50